Antibody-Targeted Cyclodextrin-Based Nanoparticles for siRNA Delivery in the Treatment of Acute Myeloid Leukemia: Physicochemical Characteristics, in Vitro Mechanistic Studies, and ex Vivo Patient Derived Therapeutic Efficacy

Molecular PharmaceuticsDOI: 10.1021/acs.molpharmaceut.6b01150

Source: Molecular Pharmaceutics - February 14, 2017 Category: Drugs & Pharmacology Authors: Jianfeng Guo, Eileen G. Russell, Raphael Darcy, Thomas G. Cotter, Sharon L. McKenna, Mary R. Cahill and Caitriona M. O ’Driscoll Source Type: research